Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S). Implantable carotid sinus baroreflex device for the treatment of drug-resistant hypertension. Australia: Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S). Technology Brief Update
. 2014 Authors' conclusions Currently there is a lack of clinical and cost-effectiveness evidence to support the use of the baroreflex stimulation to reduce hypertension. It should be noted that the Baroreflex Rheos device has been superseded by the Barostim neo, which is not available in Australia. A large, prospective RCT on the Barostim neo device is due for completion in 2015, the results of which, if favourable, will be identified by horizon scanning activities. Therefore it is recommended that no further research on behalf of HealthPACT is warranted at this time. Indexing Status Subject indexing assigned by CRD MeSH Baroreflex; Carotid Sinus; Electric Stimulation Therapy; Electrodes, Implanteds; Hypertension Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence 199 Ward Street, North Adelaide SA 5006, Australia. Tel: +61 8 8219 0900, Fax: +61 8 8219 0999 Email: asernips@surgeons.org AccessionNumber 32015000981 Date abstract record published 08/09/2015 |